Delivery Order SPE2DB20D2002-SPE2DB25FL71X
- Not listed
- The Defense Logistics Agency awarded a $14,078.16 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups, making it...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $6,760.81 under a firm fixed-price arrangement. This non-set-aside delivery order was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $22,721.30 under a firm fixed-price contract. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization programs within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,274.97 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, supporting the federal government's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $20,520.05 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $194,207.50 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed price contract. The award, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a direct procurement of this pneumococcal vaccine product to be performed at the vendor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency awarded a delivery order valued at $7,010.33 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25,018 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-set-aside, competitively awarded contract reflects a firm fixed-price arrangement with an ultimate completion date of August 28, 2025. The delivery order was executed on August 27, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL71XDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,453.56 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease across multiple age groups, representing a critical pharmaceutical commodity for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor for the Defense Health Agency and other federal healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's continued selection for delivery orders under this substantial IDC reflects its demonstrated capability to meet federal procurement requirements and support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/27/25 |